Press release
Protecting Against Rotavirus: Prophylaxis Market Analysis and Growth Prospects 2024
As per the report, the rotavirus prophylaxis market size has grown rapidly in recent years. It will grow from $8.15 billion in 2023 to $9.05 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The rotavirus prophylaxis market size is expected to see strong growth in the next few years. It will grow to $13.24 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%.
Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13045&type=smp
Rising Vaccine Courses Powering Growth In The Rotavirus Prophylaxis Market
The increasing vaccine courses are expected to propel the growth of the rotavirus prophylaxis market going forward. A vaccine course is a specific dose of vaccine that is meant to be given to a person to produce protection from a particular disease. The vaccine course dosage stimulates the immunological response, providing excellent protection against rotavirus infection. This increased immunity minimizes the risk of diseases and improves the vaccine's overall efficacy. For instance, in January 2022, according to a report published by the United Nations International Children's Emergency Fund (UNICEF), a US-based provider of humanitarian and developmental help to children, around 5.71 million courses of RV1-5 frozen rotavirus vaccine were produced 2022, with a projected increase to 9.31 million courses by 2028. Furthermore, 5.29 million courses of RV5-2 lyophilized rotavirus vaccines were manufactured in 2022, with a projected rise to 6.13 million courses by 2028. Therefore, the increasing number of vaccines will drive the rotavirus prophylaxis market.
Vaccine Development And Approvals In The Rotavirus Prophylaxis Market
Major companies operating in the rotavirus prophylaxis market are developing vaccines to meet customer requirements. Vaccine approvals involve a rigorous process that includes multiple development and testing stages. These approvals are essential in ensuring that vaccines are safe and effective for preventing this viral illness, particularly in infants and young children. For instance, in November 2022, GlaxoSmithKline plc, a UK-based pharmaceutical and biotechnology company, announced that the Food and Drug Administration (FDA) had approved an oral-dosing applicator-only presentation (liquid formulation) of ROTARIX (Rotavirus Vaccine, Live and Oral), that prevents rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4 and G9) in infants. The novel oral-dosing applicator-only presentation is entirely liquid and must not be reconstituted before use. ROTARIX lyophilized and liquid formulations are administered orally in a two-dose series, contain the same live, human-attenuated rotavirus strain and are made using comparable techniques.
The rotavirus prophylaxis market covered in this report is segmented -
1) By Treatment: Rotarix; Rotavac; Rotavin-M1; Oral Rehydration Fluid; Other Treatments
2) By Route of Administration: Oral; Parenteral; Other Route of Administrations
3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
4) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13045&type=discount
Major players in the rotavirus prophylaxis market are Pfizer Inc., Johnson & Johnson, Merck & Co., Novartis AG, Sanofi SA, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Sinovac Biotech Ltd., Astellas Pharma Inc., CSL Limited, Bharat Biotech International Limited, Daiichi Sankyo Co. Ltd., Lupin Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd., Zydus Lifescience Ltd., Emergent BioSolutions Inc., Hualan Biological Engineering Inc., Biocad Biopharmaceutical Co., Bharat Serums and Vaccines Limited, Biological E Limited, PT Bio Farma, Panacea Biotec Ltd., Shanghai Institute of Biological Products (SIBP).
Contents of the report:
1. Executive Summary
2. Rotavirus Prophylaxis Market Report Structure
3. Rotavirus Prophylaxis Market Trends And Strategies
4. Rotavirus Prophylaxis Market - Macro Economic Scenario
5. Rotavirus Prophylaxis Market Size And Growth
…..
27. Rotavirus Prophylaxis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/rotavirus-prophylaxis-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Protecting Against Rotavirus: Prophylaxis Market Analysis and Growth Prospects 2024 here
News-ID: 3626510 • Views: …
More Releases from the business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Rotavirus
Emerging Trends Influencing The Growth Of The Rotavirus Vaccine Market: Oral-Dos …
The Rotavirus Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Rotavirus Vaccine Market Size Expected to Be by 2034?
The market size for the rotavirus vaccine has seen significant expansion in recent years. It is projected to escalate from $9.18 billion…
Rising Vaccine Courses Powering Growth In The Rotavirus Prophylaxis Market: Key …
The Rotavirus Prophylaxis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Rotavirus Prophylaxis Market Size During the Forecast Period?
In recent years, there has been a quick escalation in the size of the rotavirus prophylaxis market. A substantial growth is anticipated, hopping…
Top Factor Driving Rotavirus Prophylaxis Market Growth in 2025: Rising Vaccine C …
What market dynamics are playing a key role in accelerating the growth of the rotavirus prophylaxis market?
The anticipated surge in vaccine courses is predicted to fuel the expansion of the rotavirus prophylaxis market. A course of vaccine refers to the prescribed dose of a vaccine administered to an individual for protection against a specific disease. This dosage triggers the immune response, offering robust defense against rotavirus infection. This enhanced immunity…
Top Factor Driving Rotavirus Prophylaxis Market Growth in 2025: Rising Vaccine C …
What market dynamics are playing a key role in accelerating the growth of the rotavirus prophylaxis market?
The anticipated surge in vaccine courses is predicted to fuel the expansion of the rotavirus prophylaxis market. A course of vaccine refers to the prescribed dose of a vaccine administered to an individual for protection against a specific disease. This dosage triggers the immune response, offering robust defense against rotavirus infection. This enhanced immunity…
Top Factor Driving Rotavirus Vaccine Market Growth in 2025: Impact Of Rising Bir …
How Big Is the Rotavirus Vaccine Market Expected to Be, and What Will Its Growth Rate Be?
The market size for the rotavirus vaccine has seen a significant expansion in the recent past. The sector, which is projected to ascend from $9.18 billion in 2024 to $10.14 billion in 2025, will experience a compound annual growth rate (CAGR) of 10.5%. Several factors have propelled the growth in this period including heightened…
Rotavirus Vaccines Market - Empowering Immunity, Eradicating Rotavirus: Champion …
Newark, New Castle, USA: The "Rotavirus Vaccines Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Rotavirus Vaccines Market: https://www.growthplusreports.com/report/rotavirus-vaccines-market/8682
This latest report researches the industry structure, sales, revenue,…
